demonstrated that SLC11A1 gene silencing using RNAi in mice reduced the frequency of T1DM and protected against experimental autoimmune encephalomyelitis, demonstrating a role for SLC11A1 in autoimmunity (47). Here, SLC11A1 is linked to type 1 diabetes mellitus.